- Remove All
- Your shopping cart is currently empty
CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.CMLD-2 induces apoptosis and exhibits antitumor effects through MAD2 downregulation. CMLD-2 (1-75 μM ; 24-72 h) had an inhibitory effect on the viability of thyroid cancer cells.CMLD-2 (20-30 μM ; 24-48 h) activated caspases and induced apoptosis in H1299 and A549 cells.CMLD-2 (30 μM ; 24-48 h) induced G1 cell cycle arrest in H1299 and A549 cells and mitochondrial perturbation. CMLD-2 (30 μM ; 24-48 h) reduced the expression of HuR and HuR-regulated mRNAs and proteins in H1299 cells.CMLD-2 (35 μM ; 72 h) decreased the directional migration ability of SW1736, 8505C, BCPAP and K1 cells.CMLD-2 induced the migration of SW1736, 8505C, BCPAP and K1 cells with a strong decrease in MAD2 mRNA levels.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $98 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $413 | In Stock | |
25 mg | $676 | In Stock | |
50 mg | $943 | In Stock | |
100 mg | $1,270 | In Stock | |
500 mg | $2,530 | In Stock | |
1 mL x 10 mM (in DMSO) | $272 | In Stock |
Description | CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.CMLD-2 induces apoptosis and exhibits antitumor effects through MAD2 downregulation. CMLD-2 (1-75 μM ; 24-72 h) had an inhibitory effect on the viability of thyroid cancer cells.CMLD-2 (20-30 μM ; 24-48 h) activated caspases and induced apoptosis in H1299 and A549 cells.CMLD-2 (30 μM ; 24-48 h) induced G1 cell cycle arrest in H1299 and A549 cells and mitochondrial perturbation. CMLD-2 (30 μM ; 24-48 h) reduced the expression of HuR and HuR-regulated mRNAs and proteins in H1299 cells.CMLD-2 (35 μM ; 72 h) decreased the directional migration ability of SW1736, 8505C, BCPAP and K1 cells.CMLD-2 induced the migration of SW1736, 8505C, BCPAP and K1 cells with a strong decrease in MAD2 mRNA levels. |
Targets&IC50 | HuR-ARE:350 nM(Ki) |
In vitro | CMLD-2 (35 μM ; 72 h) impairs directional migration ability and significantly diminishes MAD2 mRNA levels in SW1736, 8505C, BCPAP, and K1 cells.[2] CMLD-2 (20-30 μM ; 24-48 h) triggers caspase activation and induces apoptosis in H1299 and A549 cells.[2] CMLD-2 (30 μM ; 24-48 h) causes G1 cell cycle arrest and disrupts mitochondrial function in H1299 and A549 cells.[2] CMLD-2 (30 μM ; 24-48 h) decreases the expression of HuR and HuR-regulated mRNAs and proteins in H1299 cells.[2] CMLD-2 (1-75 μM ; 24-72 h) suppresses thyroid cancer cell viability.[3] CMLD-2 (0.1-10 μM) reduced the activity of mouse and human sensory neurons.[5] |
In vivo | CMLD-2 (0.3 μg, 1 μg, 3 μg ; i.pl.) attenuated NGF (left), and IL-6 (right) induced mechanical hypersensitivity during the acute and priming phase in male mice.[5] |
Molecular Weight | 513.58 |
Formula | C31H31NO6 |
Cas No. | 958843-91-9 |
Smiles | COc1ccc(cc1)C(CC(=O)N1CCCC1)c1c(OC)cc(OC)c2c(cc(=O)oc12)-c1ccccc1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 65 mg/mL (126.56 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.